Company Overview:

Global Health Clinics Ltd. (CSE: MJRX) operates a two-part system of customer lead generation and conversion, through its network of pavilions and the ownership and operation of five medical clinics that aim to connect Canadians with ACMPR license producers by advancing the understanding of medical cannabis and its applications, and the provision of related services and products for patients suffering from illness from which they may find relief with medical cannabis, including facilitating access to qualified health care practitioners, independent medical cannabis evaluations and related advice. 

This Report covers the Price Action, Technical Indicators Analysis along with the Support Levels, Resistance Levels, and Recommendations on this stock.

Fundamental Highlights:

Scalable Growth Strategy Supported by Operational Expansion Plans: The Company is positioning for rapid expansion by strengthening its managerial, operational, and financial systems to support increasing demand and strategic partnerships. Planned enhancements to infrastructure and controls are designed to enable scalable growth, improve execution efficiency, and support long-term value creation in a dynamic and evolving market environment.

Key Investment Risks: Price Volatility, Technological Risk, Permitting & Regulatory Risk, Inflation, low volume, thin liquidity, etc 

MJRX’s Technical Observation:

Global Health Clinics appears to be forming a base after a prolonged decline, with price stabilizing and holding above recent support near 0.03. The 14-week SMMA is flattening, signalling trend stabilization, while RSI has moved around 50, reflecting strengthening momentum. Gradual higher lows suggest improving sentiment and potential for continued upside recovery.

MJRX’s Daily Price Chart

As per the above-mentioned price action and technical indicators analysis, a ‘Speculative Buy’ rating has been given Global Health Clinics Ltd. (CSE: MJRX) at the closing market price of CAD 0.035, as of 17^th February 2026. Individuals can evaluate the stock based on the support and resistance levels provided in the report in case of keen interest taking into consideration the risk-reward scenario. 

Markets are trading in a highly volatile zone currently due to certain Macro & Micro-economic data and prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels as on February 17, 2026. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Dividend Yield may vary as per the stock price movement. 

Note 5: Kalkine reports are prepared based on the stock prices captured either from REFINITIV or Trading View. Typically, REFINITIV or Trading View may reflect stock prices with a delay which could be a lag of 25-30 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and the uptrend may take a pause due to profit booking or selling interest.

Stop-loss: In general, it is a level to protect further losses in case of any unfavourable movement in the stock prices.